Dermatological Abnormalities in Beta-thalassemia Major
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03894605|
Recruitment Status : Unknown
Verified March 2019 by Neveen Mamdoh Farag, Assiut University.
Recruitment status was: Not yet recruiting
First Posted : March 28, 2019
Last Update Posted : March 28, 2019
Information provided by (Responsible Party):
Neveen Mamdoh Farag, Assiut University
- Study Details
- Tabular View
- No Results Posted
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||March 2, 2021|
|Estimated Study Completion Date :||April 2, 2021|
Publications of Results:
El-Dash H, Adel S. Cutaneous manifestations in Egyptian children with beta-thalassemia major: Relationship with serum ferritin, thyroid profile, and treatment modalities. Pediatr Dermatol. 2018 Sep;35(5):639-643. doi: 10.1111/pde.13570. Epub 2018 Jun 26.
Dogramaci AC, Savas N, Ozer B, Duran N. Skin diseases in patients with beta-thalassemia major. Int J Dermatol. 2009 Oct;48(10):1057-61. doi: 10.1111/j.1365-4632.2009.04176.x.